Stocks · Health care · Biological Products, (No Diagnostic Substances)

Kymera Therapeutics, Inc.

KYMR Clue Score27
United States Fiscal year ends December CIK 0001815442 Results filed 29 Oct 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Baker Bros. Advisors LP
11 Dec 2025
Director
Buy indirect
1,838,621
$86.00
$158.12M
Baker Bros. Advisors LP
11 Dec 2025
Director
Buy indirect
167,192
$86.00
$14.38M
Showing 250 of 595 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 265
Amendments (4/A) skipped 3
Filings about a different issuer 0
Unreadable filings 0
Joint filings 34
Sales on a Rule 10b5-1 plan 184
Sales straight out of an exercise 200
Sales at will 132
Transactions with no price 0
Shares from compensation/vesting 29,275,899
Sales filed before the plan box existed 72
History held since 21 Aug 2020